PlainRecalls
FDA Devices Moderate Class II Terminated

Percept PC Implantable Neurostimulator (INS) - Product Usage: The Percept PC is a neurostimulation device for deep brain stimulation therapy. It is indicated for DBS treatment for Parkinson s disease, essential tremor, dystonia, obsessive-compulsive disorder, and epilepsy.

Reported: December 23, 2020 Initiated: November 19, 2020 #Z-0612-2021

Product Description

Percept PC Implantable Neurostimulator (INS) - Product Usage: The Percept PC is a neurostimulation device for deep brain stimulation therapy. It is indicated for DBS treatment for Parkinson s disease, essential tremor, dystonia, obsessive-compulsive disorder, and epilepsy.

Reason for Recall

A software anomaly in the A620 Patient Programmer application was identified that results in failure to connect with the Percept PC device.

Details

Recalling Firm
Medtronic Neuromodulation
Units Affected
12 devices
Distribution
US Nationwide distribution including in the states of Arizona, California, New Hampshire, Pennsylvania, Tennessee, Texas, Washington.
Location
Minneapolis, MN

Frequently Asked Questions

What product was recalled?
Percept PC Implantable Neurostimulator (INS) - Product Usage: The Percept PC is a neurostimulation device for deep brain stimulation therapy. It is indicated for DBS treatment for Parkinson s disease, essential tremor, dystonia, obsessive-compulsive disorder, and epilepsy.. Recalled by Medtronic Neuromodulation. Units affected: 12 devices.
Why was this product recalled?
A software anomaly in the A620 Patient Programmer application was identified that results in failure to connect with the Percept PC device.
Which agency issued this recall?
This recall was issued by the FDA Devices on December 23, 2020. Severity: Moderate. Recall number: Z-0612-2021.